Announcements Trials
Browse Landscape

Status

Completed 20Recruiting 11Active not recruiting 9Unknown 8Not yet recruiting 4Terminated 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1

Conditions

Postoperative Complications 1Ovarian Neoplasms 1Multiple Myeloma 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Geriatric Assessment × Clear all
NCT05276622 2024-12-12

PaCE-MM

UNC Lineberger Comprehensive Cancer Center

Terminated
64 enrolled
Plasma cell

Multiple Myeloma

NCT01175967 2015-10-12

Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer

UNC Lineberger Comprehensive Cancer Center

Terminated
11 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡